Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BJUI Compass is Scopus-indexed (Q2, CiteScore 2.8), WoS ESCI, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2688-4526Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 236 / 597 | 60th | Q2 |
| Urology | 60 / 123 | 51st | Q2 |
| Nephrology | 46 / 88 | 48th | Q3 |
| Oncology | 269 / 428 | 37th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q2, CiteScore 2.8.
BJUI Compass is Q2 in Surgery (rank 236 of 597), Q2 in Urology (rank 60 of 123) and Q3 in Nephrology (rank 46 of 88), by CiteScore 2025. It is ranked in 4 subject areas in all.
BJUI Compass is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.8, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.605, quartile Q2, with an H-index of 19.
The publisher lists an article processing charge of about US$2,770 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BJUI Compass is published by John Wiley and Sons Inc. Its ISSN is 2688-4526.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
BJUI Compass has an h-index of 24 and a 2-year mean of 1.62 citations per paper (OpenAlex). Its Scopus CiteScore is 2.8, quartile Q2. On 2-year citations it ranks #184 of 585 Scopus journals in Surgery.
BJUI Compass published 176 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (27.8%), United Kingdom (13.6%) and Australia (6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.